Affiliation:
1. Molecular Sciences Lab National Institute of Immunology New Delhi Aruna Asaf Ali Marg New Delhi New Delhi 110067 India
2. Wellman Center for Photomedicine, Massachusetts General Hospital Harvard Medical School Boston MA 02114 USA
Abstract
ScopeThe emerging role of gut microbiota and their metabolites in the modulation of the gut‐brain axis has received much attention as a new hope for the treatment of hard‐to‐treat chronic neurodegenerative diseases like Alzheimer's disease. The naturally occurring polyphenols can restore the gut‐brain axis by modulating gut microbiota and brain neurotransmitters. The Indian traditional medicine Triphala, a rich source of polyphenols, has been used on humans based on Prakriti or disease conditions for many years.Methods and resultsIn this study, the dual mode (morning and evening) action of Triphala is used to provide scientific evidence of its superior preventive and therapeutic efficacy in C57BL/6 and 5xFAD, APP/PS1 transgenic mouse model of Alzheimer's disease. The study observes that Triphala treatment has significantly improved cognitive function, by modulating the APP pathway, reducing inflammation, and restoring the gut‐brain axis by increasing the gut microbiota phyla of Bacteroides, Proteobacteria, Actinobacteria, etc., involved in maintaining the gut homeostasis.ConclusionsThe study paves a new path for using dual modes of Triphala alone or in combination to treat incurable AD.
Subject
Food Science,Biotechnology